Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MOMETASONE FUROATE
PCO Manufacturing
D07AC13
MOMETASONE FUROATE
0.1 %w/w
Ointment
Product subject to prescription which may be renewed (B)
Corticosteroids, potent (group III)
Authorised
2011-05-06
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER ELOCON ® 0.1% W/W OINTMENT Mometasone Furoate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What ELOCON is and what it is used for 2. Before you use ELOCON 3. How to use ELOCON 4. Possible side effects 5. How to store ELOCON 6. Further information 1. WHAT ELOCON IS AND WHAT IT IS USED FOR ELOCON Ointment is one of a group of medicines called topical corticosteroids. It is classified as a “potent corticosteroid”. These medicines are put on the surface of the skin to reduce the redness and itchiness caused by certain skin problems. In adults and children, ELOCON Ointment is used to reduce redness and itchiness caused by certain skin problems called psoriasis or dermatitis. Psoriasis is a skin disease in which itchy, scaly, pink patches develop on the elbows, knees, scalp and other parts of the body. Dermatitis is a condition brought on by the skin reacting to outside agents e.g. detergents, causing the skin to become red and itchy. 2. BEFORE YOU USE ELOCON DO NOT USE ELOCON − if you are allergic (hypersensitive) to mometasone furoate, any of the other ingredients of ELOCON or to other similar medicines. − on any other skin problems as Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Elocon 0.1% w/w Ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Mometasone Furoate 0.1% w/w (equivalent to 1.0mg/g) Excipients: Propylene glycol stearate For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Ointment _Product imported from Greece and Spain:_ A white to off-white, opaque ointment 4 CLINICAL PARTICULARS As per PA1286/035/002 5 PHARMACOLOGICAL PROPERTIES As per PA1286/035/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Hexylene glycol Phosphoric acid Propylene glycol stearate White beeswax White soft paraffin Purified water 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/07/2015_ _CRN 2163530_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER 30g aluminium tubes with a plastic cap 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Unit 10 Ashbourne Business Park Rath Ashbourne Co. Meath 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA465/268/2 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 6th May 2011 10 DATE OF REVISION OF THE TEXT July 2015 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/07/2015_ _CRN 2163530_ _page number: 2_ Read the complete document